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INTRODUCTION
Pelvic organ prolapse (POP) is a significant worldwide 
health issue for women [1]. Cystocele or anterior vaginal 
wall prolapse is the most common type of POP in women 
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[2]. Approaches to the surgical management of POP have 
undergone several paradigm shifts over the last few 
decades [3]. The traditional anterior repair of  cystocele 
is associated with a high failure rate, and paravaginal 
repair is not superior to the traditional anterior repair [1]. 
www.kjurology.org
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Surgical approaches using polypropylene mesh have been 
widely performed in recent years with high success and low 
recurrence rates [4].
POP and stress urinary incontinence (SUI) often coexist. 
There is a controversy regarding the surgical repair of 
both conditions at the same time. When performed in one 
session, there is usually a specific procedure for prolapse 
and another for SUI. After the completion of the cystocele 
repair, suburethral tape made of polypropylene is placed 
midurethra, via the transobturator or retropubic route [5]. 
Synthetic four-arm polypropylene mesh, Nazca-Tc 
(Promedon, Cordoba, Argentina), was introduced to correct 
the anterior compartment with the ability to treat SUI at 
the same time. The mesh has four anchoring arms that 
facilitate a double transobturator approach for cystocele 
repair (Fig. 1).
A multicenter trial previously reported a 12-month cure 
rate of  73% for anterior prolapse by use of  this system 
[6]. The aim of the present prospective single-center trial 
was to evaluate the safety and efficacy of  the four-arm 
polypropylene mesh (Nazca-Tc) in the treatment of high-
stage cystocele and to evaluate clinical outcomes in a 
subgroup of patients with simultaneous SUI via the double 
transobturator approach with a mean follow-up of 2 years.
MATERIALS AND METHODS
From September 2010 to August 2013, a prospective 
single-arm study was designed to evaluate the results of 
the Nazca-Tc (Promedon, Cordoba, Argentina) system in the 
treatment of high-stage symptomatic cystocele in women. 
The proposal was approved by the Ethics Committee of 
the Urology-Nephrology Research Center, Labbafinejad 
Hospital, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran, and all patients provided written informed 
consent. The inclusion criteria were as follows: symptomatic 
cystocele stage≥3 with or without SUI. Exclusion criteria 
were active urinary tract or vaginal infection at the time of 
the operation, evidence of any tearing or severe weakness in 
the anterior vaginal mucosa, history of previous placement 
of anterior vaginal wall mesh, or any history or evidence of 
urogenital malignancies.
Preoperative evaluation consisted of  patient history, 
the Pelvic Floor Distress Inventory short form (PFDI-20), 
the Pelvic Floor Impact Questionnaire short form (PFIQ-
7), physical examination, International Continence Society 
Pelvic Organ Prolapse Quantification (POP-Q) system 
[7], and cough stress test, with and without reduction of 
prolapsed structures. Paraclinical evaluation included 
urinalysis and culture and measurement of postvoid residual 
(PVR) urine by bladder ultrasound scan. In cases of severe 
urinary urgency, urgency incontinence or frequent urinary 
retention, a multichannel urodynamic study was performed 
as well. Patients underwent cystocele repair with the Nazca-
Tc system.
The procedure was performed with the patient in the 
lithotomy position under general or spinal anesthesia. A 
16-French Foley catheter was inserted through the urethra 
in the bladder. A midline incision was created in the 
anterior vaginal wall mucosa from the bladder neck and 
extended to the cervix (in case of previous hysterectomy, 
it was extended to the vaginal cuff); wide dissection was 
carried out laterally to the pelvic sidewalls. The first stab 
incisions at each side were placed in the anteromedial edge 
of the obturator foramen at the level of the clitoris, and 
the proximal incisions were placed 2 cm laterally and 3 cm 
inferior from the distal incisions. The helical transobturator 
needles were passed through the groin incision and the 
obturator space and were then brought to the vaginal 
cavity. The arms of the mesh were connected to the tip of 
the needle and brought out through the groin incision. 
The central sheet of the mesh was placed underneath 
the bladder base in a tension-free manner and was sutured 
at the proximal and distal edges to the cervix and bladder 
neck by use of 2-0 separate Vicryl sutures. The arms were 
placed under gentle traction from both sides to adjust the 
elevation of  the bladder. The extra lengths of  the arms 
were cut at the level of  the groin incisions. The vaginal 
mucosa was sutured in an overlying manner by use of 2-0 
separate Vicryl sutures. At the end, the mesh was covered 
by two layers of  vaginal mucosa. Vaginal packing was 
placed and the Foley catheter remained in situ for 12 hours. 
Concomitant surgeries consisted of sacrospinous ligament 
fixation by use of the Capio device (Boston Scientific, Natick, Fig. 1. The Nazca-Tc pelvic organ prolapse repair system.
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MA, USA) in six patients. 
Patients presented to follow-up visits at 2 weeks and 1 
and 3 months postoperatively and every 6 months thereafter. 
Objective success was defined as cystocele stage≤1 and a 
negative result on a cough stress test and subjective success 
as improvement in the PFDI and PFIQ. Any complications 
were recorded as well. PFDI and PFIQ scores and PVR were 
compared pre- and postoperatively by use of paired t-tests.
RESULTS
A total of 71 patients underwent cystocele repair with 
the Nazca-Tc system via the double transobturator approach. 
Seven patients were lost to longer follow-up and 64 women 
had complete follow-up. The patients’ mean age was 65.5±8.57 
years. Sixty women were postmenopausal (93.7%) without 
having receiving hormonal replacement therapy. Nineteen 
(29.6%) and 20 patients (31.2%) had a past medical history 
of  previous cystocele repair by conventional anterior 
colporrhaphy and abdominal hysterectomy, respectively. 
None of  the patients had any history of  previous anti-
incontinence surgery (Table 1).
The most common preoperative presenting symptom 
was the sensation of a lump (92.1%). Other symptoms were 
obstructive (89.2%) and irritative (62.5%) lower urinary tract 
symptoms. Thirty-eight and 12 patients (78%) suffered from 
frank and occult SUI, respectively. Twenty-three patients 
(35.9%) complained of urinary urge incontinence. Only 18 
(28.1%) and 11 patients (17.1%) presented with recurrent 
urinary tract infection and urinary retention, respectively 
(Fig. 2).
Cystocele was stages 4 and 3 in 56 (87.5%) and 8 women 
(12.5%), respectively. Sixty-two women had posterior vaginal 
wall prolapse (stage 1, 50%; stage 2, 42%; and stage 3, 5%) as 
well. Only 6 of 64 patients (9.3%) had simultaneous vaginal 
vault prolapse.
The procedure was uneventful in all patients. Two patients 
were transfused with one unit of blood postoperatively. Also, 
two patients complained of pain (groin/pelvic) that required 
more than 1 week of analgesic treatment. The mean follow-up 
time was 24 months (range, 10–36 months). The anatomical 
success rate was 87.5%. Six and two patients had cystocele 
stages 2 and 3, respectively. The subjective success rate was 
92.1%. The PFDI and PFIQ were significantly improved after 
surgery (p<0.001) (Table 2). Pre- and postoperative mean PVR 
was 102 cm3 versus 19 cm3 (p<0.001). Postoperative symptoms 
are listed in Table 3.
Table 2. Quality of life at 2-year follow-up
Baseline 2-Year follow-up Paired difference p-value
PFDI-20 39.5±8.3 8.7±7.9 30.7±9.6 <0.001
PFIQ-7
   POPIQ 76.5±8.9 20.2±13.9 56.3±13.2 <0.001
   UIQ 74.6±17.7 25.7±16.0 48.8±19.4 <0.001
   CRAIQ 23.7±16.3 14.7±14.8 9.0±8.0 <0.001
Sumscore 173.0±28.2 60.4±33.1 112.0±29.5 <0.001
Values are presented as mean±standard deviation.
PFDI-20, Pelvic Floor Distress Inventory short form; PFIQ-7, Pelvic Floor Impact Questionnaire short form; POPIQ, Pelvic Organ Prolapse Distress 
Inventory Questionnaire; UIQ, Urinary Distress Inventory Questionnaire; CRAIQ, Colorectal-Anal Distress Inventory Questionnaire. 
Table 1. Demographic data
Parameter Value
Age (y) 65.5 (47–80)
Body mass index (kg/m2) 28.04 (22–33)
Parity 4.13 (2–11)
Menopause 60 (93.7)
Prior cystocele repair 19 (29.68)
Prior abdominal hysterectomy 20 (31.25)
Prior anti incontinence surgery 0 (0)
Values are presented as mean (range) or number (%).
Fig. 2. Symptoms at presentation. UTI, urinary tract infection; SUI, stress 
urinary incontinence.
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Of the 50 patients who complained of SUI, 41 (82%) were 
cured. One patient with persistent SUI underwent mini-sling 
surgery at follow-up and was cured postoperatively. Two 
patients developed de novo SUI.
The mesh exposure rate was 4.6% (3 patients). Two 
patients were managed with conservative local therapy. 
One patient underwent revision and partial excision of the 
exposed part of the mesh.
Only 29 of 64 patients (45.3%) were sexually active at 
baseline. Of these, 20 patients reported improvement in 
sexual activity and 7 patients had no change in sexual 
function. Two patients complained of worsening dyspareunia 
after surgery.
DISCUSSION
Recurrent anterior vaginal wall prolapse may develop 
in more than 20% of patients after native tissue repair [8]. 
Between 29% and 40% of reconstructive procedures require 
repeat surgical intervention owing to anatomical failure 
within 3 years [9]. Of all recurrences, 60% are at the same 
site, mostly at the anterior compartment [10], whereas 32.5% 
occur at a different site because of the unmasking of an 
occult support defect.
Demographic, genetic, and environmental factors have 
challenged the durability of traditional suture-based native 
tissue repair and have created the impetus for pelvic 
reconstructive surgeons to seek the advantages offered by 
mesh-augmented repair [9]. In 2008, a Cochrane review of 
the surgical management of  POP in women found that 
placement of a mesh or graft during anterior vaginal wall 
repair reduces the risk of  recurrent prolapse [11]. In the 
multicenter research clinical trial with the longest follow-
up period, Nieminen et al. [12] randomized 105 and 97 women 
to surgeon-tailored transvaginal mesh and traditional 
colporrhaphy for anterior vaginal wall prolapse, respectively. 
At 3 years of follow-up, the authors reported the rates of 
recurrence of prolapse ≥stage 2 in the POP-Q system to be 
13% and 41% in the mesh and traditional repair groups, 
respectively (p<0.0001). In a prospective study, Moore et 
al. [1] evaluated 114 women with stage ≥2 anterior vaginal 
wall prolapse treated with the Perigee system (AMS Inc., 
Minnetonka, MN, USA) placed via a transobturator route. 
The clinical success rate at 24 months was 88.5%. Only 10.5% 
and 4.4% of patients complained of vaginal mesh extrusion 
and vaginal pain, respectively.
In our study, with a mean of 2 years of follow-up, anato-
mical and subjective success rates were 87.5% and 92.1%, 
respectively, which correspond to values in the literature, 
although with a different commercially available brand.
Advanced POP commonly coexists with SUI. However, 
in several patients, the SUI may become apparent when the 
prolapse is corrected. On the other hand, around one-third 
of patients with either frank or occult SUI experience relief 
from incontinence after POP repair. Therefore, patients 
with concomitant POP and SUI pose an additional challenge 
for surgical repair, involving two procedures at the same 
time [13]. Generally, for POP accompanied by SUI, there 
is a specific procedure for prolapse and another for SUI 
in the treatment strategies, either concomitant or staged. 
Sergent et al. [14] reported 97% and 81% (69% cure and 12% 
improvement) success rates for the treatment of cystocele 
and SUI, respectively, in a single operation by use of the 
transobturator subvesical mesh repair technique without 
independent suburethral tape. Palma et al. [6] reported a 
combined approach, prepubic and transobturator, in the 
treatment of cystocele and SUI with the Nazca-Tc system. 
Anterior prolapse and SUI was cured in 73% and 78% of 
their patients, respectively.
In our study, we used the Nazca-Tc system via the 
double transobturator route for the treatment of high-stage 
cystocele resulting in the cure of 82% of the patients with 
the associated symptom of SUI, without any concomitant 
procedure for SUI. The results are close to the above-
mentioned clinical studies and show that the double 
transobturator route can address SUI as well as cystocele.
The underlying mechanism of female SUI is reported 
to be weakness in the supportive mechanisms of  the 
bladder neck or laxity and hypermobility of the midurethra 
(weakness of  the pubourethral ligament). Traditional 
reconstructive surgeries such as the autologous facial sling 
technique address the first pathophysiological mechanism 
and the rationale for the new minimally invasive mi-
dure thral tapes such as tension-free vaginal tape and 
transobturator tape is repair of the second mechanism. In 
our study, it seems that the positive effect of the double 
Table 3. Postoperative symptoms
Postoperative symptom Value
Dysuria 7 (10.9)
Urinary frequency 8 (12.5)
Urinary urgency 12 (18.75)
Urgency incontinence 4 (6.25)
Stress urinary incontinence 11 (15.49)
Mixed urinary incontinence 2 (3.12)
Obstructive symptoms 5 (7.3)
Lump sensation 2 (3.12)
Values are presented as number (%).
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transobturator mesh repair was related to support of the 
bladder neck, which addresses the first pathophysiologic 
mechanism.
The most common complication surrounding mesh-
augmented repair is exposure of the mesh into the vaginal 
lumen [9]. Other less common complications are pain (vaginal, 
groin, buttock, or leg), dyspareunia, mesh contracture, 
and bladder extrusion [15,16]. According to the available 
randomized controlled trials, the rate of  vaginal mesh 
exposure ranges from 4% to 35.7%. Most erosions are treated 
under local anesthesia by partial excision, whereas the rest 
need only topical estrogen. Some cases require full removal 
[17-21]. In a recent systematic review, Abed et al. [22] reported 
an overall erosion rate of  10.3% for the synthetic mesh 
procedures.
In our study, there was no case of  bladder erosion 
by mesh, whereas the vaginal mesh exposure rate was 
4.6% (3 patients). Two of  these patients were managed 
conservatively by application of topical estrogen and only 
one patient required revision of  the exposed part of  the 
mesh. Two patients complained of pain (groin/pelvic).
An important concern with any vaginal repair of organ 
prolapse is dyspareunia. Recent studies have shown that 
vaginal mesh does not seem to have a negative impact 
on sexual function, and prospective comparative studies 
assessing mesh and traditional repair in the anterior 
compartment have shown no significant difference in the 
rate of dyspareunia [23-25].
Palma et al. [6] published their results with the Nazca-Tc 
mesh kit. The rates of mesh exposure, dyspareunia, and de 
novo enterocele were 4%, 2.7%, and 1.4%, respectively. In our 
study, 68.9% of patients who were sexually active reported 
improvement in sexual function after surgery and only 6.8% 
complained of worsening of dyspareunia.
The limitations of our study included a relatively small 
number of patients and a single arm rather than a double-
arm study design. Also, sexual inactivity in most of our cases 
prohibits extrapolation of  the results. Additional studies 
with application of the Nazca-Tc system are necessary to 
evaluate the efficacy and safety of this system.
CONCLUSIONS
In this prospective study with a mean of  2 years of 
follow-up, the Nazca-Tc system was deemed effective and 
safe in the treatment of  advanced anterior vaginal wall 
prolapse with a low rate of complications after medium-term 
follow-up. Most of the subgroup with concomitant SUI was 
cured without a second simultaneous procedure.
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